1. Promoter hypermethylation of SHOX2 and SEPT9 is a potential biomarker for minimally invasive diagnosis in adenocarcinomas of the biliary tract. Issue 1 (December 2016) Authors: Branchi, V.; Schaefer, P.; Semaan, A.; Kania, A.; Lingohr, P.; Kalff, J.; Schäfer, N.; Kristiansen, G.; Dietrich, D.; Matthaei, H. Journal: Clinical epigenetics Issue: Volume 8:Issue 1(2016) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Review of the TLK Activities Related to Water Detritiation, Isotope Separation Based on Cryogenic Distillation and Development of Barriers Against Tritium Permeation. (3rd April 2017) Authors: Cristescu, Ion; Bükki-Deme, A.; Carr, R.; Gramlich, N.; Groessle, R.; Melzer, C.; Schaefer, P.; Welte, Stefan Journal: Fusion science and technology Issue: Volume 71:Number 3(2017) Page Start: 225 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. SHOX2 and SEPT9 methylation is a potential biomarker for the diagnosis of biliary tract cancer. (2019) Authors: Branchi, V.; Schaefer, P.; Semaan, A.; Linghor, P.; Kalff, J.C.; Schäfer, N.; Christiansen, G.; Dietrich, D.; Matthaei, H. Journal: HPB Issue: Volume 21(2019)Supplement 3 Page Start: S1018 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. SHOX2 and SEPT9 Methylation is a potential biomarker for the diagnosis of biliary tract cancer. (2019) Authors: Branchi, V.; Schaefer, P.; Semaan, A.; Linghor, P.; Kalff, J.C.; Schäfer, N.; Christiansen, G.; Dietrich, D.; Matthaei, H. Journal: HPB Issue: Volume 21(2019)Supplement 3 Page Start: S566 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗